Publications

2010

Fonseca R, Richardson P, Giralt S, Lonial S, S Rajkumar V, A Stewart K, et al. Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc. 2010;85(2):197-9; author reply 201-4.
Dentice M, Marsili A, Ambrosio R, Guardiola O, Sibilio A, Paik J-, et al. The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest. 2010;120(11):4021-30.
Dadhania D, Snopkowski C, Ding R, Muthukumar T, Lee J, Bang H, et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation. 2010;90(2):189-97.
DeSancho MT, Berlus N, Christos PJ, Rand J. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. Blood Coagul Fibrinolysis. 2010;21(1):11-5.
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, H Cook T, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63.
Yang J-, Liu H, Diaz-Meco MT, Moscat J. NBR1 is a new PB1 signalling adapter in Th2 differentiation and allergic airway inflammation in vivo. EMBO J. 2010;29(19):3421-33.
Zheng H, Ying H, Wiedemeyer R, Yan H, Quayle SN, Ivanova EV, et al. PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 2010;17(5):497-509.
Das C, Tyler JK, Churchill ME. The histone shuffle: histone chaperones in an energetic dance. Trends Biochem Sci. 2010;35(9):476-89.
Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B. The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev. 2010;19(8):2088-96.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700